Livestock

EQS-News: Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success

Retrieved on: 
Wednesday, March 13, 2024

Despite a persistently challenging environment, the company succeeded in significantly increasing all key earnings figures and at EUR 540.6 million (2022: EUR 542.2 million) maintaining Group sales almost at the previous year’s record level.

Key Points: 
  • Despite a persistently challenging environment, the company succeeded in significantly increasing all key earnings figures and at EUR 540.6 million (2022: EUR 542.2 million) maintaining Group sales almost at the previous year’s record level.
  • Primarily due to the increasing weight of the higher-margin growth segment Specialty Chemicals, Alzchem succeeded in significantly increasing Group EBITDA by 32.4% to EUR 81.4 million in the fiscal year 2023 (previous year: EUR 61.4 million).
  • Operating cash flow also developed strongly in the fiscal year 2023, which was once again clearly positive at EUR 72.7 million (2022: EUR -4.2 million).
  • Thanks to them, the Alzchem Group remains on course for success,” explains Andreas Lösler, CFO of Alzchem Group AG.

Study on Foot-and-Mouth Disease Virus Results in Submission for Additional EPA Label

Retrieved on: 
Monday, March 11, 2024

This significant advancement supports the Company’s submission for an additional EPA label.

Key Points: 
  • This significant advancement supports the Company’s submission for an additional EPA label.
  • Foot-and-mouth disease (FMD) represents a critical global threat, being an extremely contagious disease affecting a wide range of cloven-hoofed animals including cows, pigs, sheep, goats, and deer.
  • TOMI’s recent study has proven SteraMist iHP technology to eliminate infectious FMDV from both porous (concrete) and non-porous (stainless steel) surfaces in the presence of organic soil load.
  • Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements.

Visa Announces Sixth Round of She’s Next Grant Program recipients, spotlighting the next generation of women entrepreneurs

Retrieved on: 
Friday, March 8, 2024

TORONTO, March 08, 2024 (GLOBE NEWSWIRE) -- Today, Visa Canada announced the recipients of its She’s Next Grant Program.

Key Points: 
  • TORONTO, March 08, 2024 (GLOBE NEWSWIRE) -- Today, Visa Canada announced the recipients of its She’s Next Grant Program.
  • Aiming to uplift women-owned small businesses, the program awards 10 winners a $10,000 CAD grant and access to an accelerated mentorship program through York University’s YSpace.
  • The She’s Next Grant Program builds on our track record of supporting small businesses and recognizes women face a myriad of challenges on the road to success,” said Sarah Steele, Senior Director, Small Business Product at Visa.
  • Customers can buy, sell and discover clothing made specifically for tall women with access to over 20 tall brands and counting.

FSIS Commends Appointment of Dr. Kis Robertson Hale as Chief Veterinarian Officer of USPHS

Retrieved on: 
Friday, March 1, 2024

WASHINGTON, March 01, 2024 (GLOBE NEWSWIRE) -- The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) commends the appointment by the U.S. Public Health Service (USPHS) of Dr. Kis Robertson Hale as Chief Veterinarian Officer.

Key Points: 
  • WASHINGTON, March 01, 2024 (GLOBE NEWSWIRE) -- The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) commends the appointment by the U.S. Public Health Service (USPHS) of Dr. Kis Robertson Hale as Chief Veterinarian Officer.
  • Dr. Robertson Hale is a Rear Admiral in the USPHS Commissioned Corps and serves as FSIS’ Chief Public Health Veterinarian and Deputy Assistant Administrator of the Office of Public Health Science, positions that she will continue to hold.
  • In her new appointment as Chief Veterinarian Officer of the USPHS, Dr. Robertson Hale will provide expert guidance to the Office of the Surgeon General and the U.S. Department of Health and Human Services on matters related to veterinary recruitment, assignment, deployment, retention and career development.
  • Robertson Hale’s appointment as Chief Veterinarian Officer by the U.S.

New collaboration between Boehringer Ingelheim and Sleip leverages AI-technology to help detect lameness in horses

Retrieved on: 
Monday, February 19, 2024

A new global commercial partnership between Boehringer Ingelheim and Sleip will expand access to AI to enhance detection, diagnosis and treatment of lameness in horses.

Key Points: 
  • A new global commercial partnership between Boehringer Ingelheim and Sleip will expand access to AI to enhance detection, diagnosis and treatment of lameness in horses.
  • This partnership delivers on the shared commitment of Boehringer and Sleip to deliver innovative solutions that help veterinary professionals continue to advance their profession and improve the care and wellbeing of horses.
  • Changes in gait and signs of lameness can be less pronounced at first and difficult to detect.
  • Through this collaboration, Boehringer will support the introduction of the pioneering Sleip app to the veterinary community, making this technology even more accessible.

Statement from Xcel Energy regarding wildfires in the Texas Panhandle

Retrieved on: 
Thursday, March 7, 2024

Xcel Energy (XEL) issued the following statement regarding the wildfires in the Texas Panhandle:

Key Points: 
  • Xcel Energy (XEL) issued the following statement regarding the wildfires in the Texas Panhandle:
    Our thoughts continue to be with the families and communities impacted by the wildfires in the Texas Panhandle.
  • Xcel Energy has been cooperating with the investigations into the wildfires and has been conducting its own review.
  • Xcel Energy notes that the Windy Deuce fire reportedly impacted many structures in and around Fritch, Texas.
  • Statement from Bob Frenzel, Chairman, President and CEO of Xcel Energy:
    “Xcel Energy, through our Southwestern Public Service Company (SPS) subsidiary, has operated in the Texas Panhandle for more than 100 years.

Mountain Valley MD Provides Business Update, Appoints New CFO

Retrieved on: 
Friday, March 1, 2024

The MVMD team and our extensive network of partners has made significant progress advancing our commercialization priorities,” stated Dennis Hancock, President & CEO of Mountain Valley MD.

Key Points: 
  • The MVMD team and our extensive network of partners has made significant progress advancing our commercialization priorities,” stated Dennis Hancock, President & CEO of Mountain Valley MD.
  • To date, the Company has worked on a range of formulations for Quicksome™-powered product applications, including sleep, energy, appetite suppressant, cognition, immunity, calm, and pain relief.
  • The Company believes this will be valuable in its business development efforts and broad growth plans for its nutraceutical line of business.
  • Since July 2009, his tenure at Malaspina Consultants Inc. has been marked by CFO and accounting roles for various public and private companies across multiple industries.

Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health

Retrieved on: 
Thursday, February 29, 2024

Based on extensive analysis and good faith engagement with Elanco, it appears that the biggest barriers to success are the Company’s insular Board and unaccountable CEO.

Key Points: 
  • Based on extensive analysis and good faith engagement with Elanco, it appears that the biggest barriers to success are the Company’s insular Board and unaccountable CEO.
  • Previously served on the Executive Leadership Team of Health for Animals, an organization that focuses on animal health products and animal well-being, and the Nutrition and Technology Innovation Advisory Board of Kiasco Animal Health, an animal health event series that connects innovation and investments.
  • Mr. Wallace is an experienced animal health and veterinary executive, most recently leading one of the largest animal health companies in the world.
  • Former Chief Executive Officer (North America/Pacific) of Ceva Santé Animale, the fifth largest animal health company worldwide.

Tri Counties Bank Donates $30,000 for First-Time Future Farmers of America Students in Tulare County

Retrieved on: 
Tuesday, February 27, 2024

Tri Counties Bank announced a donation of $30,000 to the Tulare County Foundation for Ag Education and Youth in support of the “Sow the Seeds” Scholarship Program.

Key Points: 
  • Tri Counties Bank announced a donation of $30,000 to the Tulare County Foundation for Ag Education and Youth in support of the “Sow the Seeds” Scholarship Program.
  • View the full release here: https://www.businesswire.com/news/home/20240227700644/en/
    Tri Counties Bank presents Tulare County Ag Foundation with a $30,000 donation for the “Sow the Seeds” Scholarship Program.
  • (Photo: Business Wire)
    The "Sow the Seeds" Scholarship Program supports low-income high school students in Tulare County who are interested in joining Future Farmers of America (FFA).
  • “Tri Counties Bank believes in investing in our students, who will, in turn, strengthen and lead our communities,” said Brett Lew, Senior Vice President and Commercial Lending Regional Manager for Tri Counties Bank.

Global Microbiome Research Report 2023: Market Booming with Breakthrough Treatments for Recurrent C. Difficile Infection, Fecal Microbial Transplantation (FMT) Emerges as a Game-Changer - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 21, 2024

The microbiome therapeutics market is successfully commercializing Seres Therapeutics' SER-109 and Rebiotix's RBX-2660 for recurrent Clostridium difficile infection (Recurrent C. difficile).

Key Points: 
  • The microbiome therapeutics market is successfully commercializing Seres Therapeutics' SER-109 and Rebiotix's RBX-2660 for recurrent Clostridium difficile infection (Recurrent C. difficile).
  • While integrated omics-based projects are underway, researchers focus more on differences in gut microbiota between individuals that may be associated with disease expression.
  • This report covers the efforts of companies involved in the microbiome market.
  • Trends in the global microbiome market are also summarized by country (and some areas), and the current market size, competitive landscape, and challenges are analyzed and forecasted for the future.